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A B S T R A C T
Glutathione (GSH) biosynthesis is essential for cellular redox homeostasis and antioxidant defense. The rate-
limiting step requires glutamate-cysteine ligase (GCL), which is composed of the catalytic (GCLc) and the
modulatory (GCLm) subunits. To evaluate the contribution of GCLc to endothelial function we generated an
endothelial-speciﬁc Gclc haplo-insuﬃcient mouse model (Gclc e/+ mice). In murine lung endothelial cells
(MLEC) derived from these mice we observed a 50% reduction in GCLc levels compared to lung ﬁbroblasts from
the same mice. MLEC obtained from haplo-insuﬃcient mice showed signiﬁcant reduction in GSH levels as well
as increased basal and stimulated ROS levels, reduced phosphorylation of eNOS (Ser 1177) and increased eNOS
S-glutathionylation, compared to MLEC from wild type (WT) mice. Studies in mesenteric arteries demonstrated
impaired endothelium-dependent vasodilation in Gclc(e/+) male mice, which was corrected by pre-incubation
with GSH-ethyl-ester and BH4. To study the contribution of endothelial GSH synthesis to renal ﬁbrosis we
employed the unilateral ureteral obstruction model in WT and Gclc(e/+) mice. We observed that obstructed
kidneys from Gclc(e/+) mice exhibited increased deposition of ﬁbrotic markers and reduced Nrf2 levels. We
conclude that the preservation of endothelial GSH biosynthesis is not only critical for endothelial function but
also in anti-ﬁbrotic responses.
1. Introduction
Endothelial dysfunction constitutes a major challenge from both the
biological and clinical standpoints as it is fundamentally associated to
the vascular damage present in major pathological entities such as
hypertension, diabetes, atherosclerosis, and aging [1]. An important
body of literature supports a causative link between oxidative distress
and impaired vascular function [2,3]. Since the discovery of en-
dothelium-derived relaxing factor (EDRF), later identiﬁed as nitric
oxide (NO), overwhelming evidence has been mounted regarding the
disturbed redox state of endothelial cells and therefore their inability to
maintain adequate vasodilation. At the cellular level, antioxidant re-
sponses to injury are elicited through multiple pathways. Among these
pathways, the endogenous nucleophile glutathione (GSH) is of
paramount importance for redox homeostasis, due to its high in-
tracellular concentrations (1–10 mM), its capacity to interact with
peroxidases and its potential to act as an electron donor for free radicals
[4–6]. GSH synthesis proceeds through two major steps regulated by
the enzymes glutamate cysteine ligase (GCL) and glutathione synthe-
tase (GS). GCL is the rate-limiting enzyme in the biosynthesis of GSH.
GCL has been the object of intense study regarding the regulation of its
expression and activity [7]. GCL is a heterodimeric holoenzyme that
includes two regulatory domains, the catalytic (GCLc, 73 kDa) and the
modiﬁer (GCLm, 33 kDa) subunits; each of them is the object of distinct
regulation [8,9]. The interaction between the two subunits and that of
both of them together with their common substrates, cysteine and
glutamate, dictates the ﬁnal eﬃciency of GSH synthesis [10].
Dysregulation of GSH synthesis has been described in several
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pathological conditions including liver injury [11], diabetes [12],
neurological disorders [13], organ ﬁbrosis [14] and cardiovascular
disease [15]. Human polymorphisms of GCLc and/or GCLm may also
result in decreased GSH synthesis and severe pathological phenotypes
[16,17]. Genetic ablation of Gclm in mice is associated with impaired
vascular reactivity [18], ovarian failure [19], lung inﬂammation [20]
and mitochondrial dysfunction [21]. Of interest, the relationship be-
tween alterations in the redox status and ﬁbrogenesis is intimately re-
lated to GSH homeostasis [14]. In this regard, it has been demonstrated
that TGF-β decreases the expression of GCL [22] and our group re-
ported that a speciﬁc miRNA, miR-433 was in part responsible of this
repression mechanism [14,23,24]. However, due to the lethal em-
brionary phenotype of Gclc null mice, the speciﬁc role of the vascular
suppression of GCLc has been diﬃcult to address in vivo. In this work,
we present data regarding the generation and characterization of con-
ditionally endothelial-deﬁcient Gclc mice. We found that endothelial
haplo-insuﬃciency is suﬃcient to promote endothelial dysfunction in
mesenteric beds, leading to eNOS inactivation in endothelial cells of
heterozygous mice. In addition, these mice express reduced levels of the
master regulator of antioxidant defense, Nrf2 and are prone to renal
ﬁbrosis.
2. Material and methods
2.1. Generation of endothelial-speciﬁc Gclc(e/+) Knockout Mice
Tie2-Cre transgenic mice were obtained from The Jackson
Laboratory (Bar Harbor, ME). We generated endothelial-speciﬁc Gclc
knockout [Gclc(e/+)] mice by intercrossing Gclc(f/f) mice with Tie2-
Cre transgenic mice. The ﬂoxed Gclc mouse line, described in [25] was
provided under agreement by Professors Ying Chen and Vasilis Vasiliou,
from the University of Colorado. We conducted all studies on litter-
mates. Animals were handled in agreement with the Guide for the Care
and Use of Laboratory Animals contained in Directive 2010/63/EU of
the European Parliament.
2.2. PCR analysis
For diﬀerentiation of the Gclc(f) versus Gclc(+) allele, genomic DNA
isolated from tails was analyzed and genotyping was conﬁrmed by PCR
analysis using speciﬁc primers for DNA ampliﬁcation (Sigma, St. Louis,
MO) as described in [25]. The Gclc(f) allele was detected using primers
A (GGGTGTTGG GTCGTTTGT) within the NEO gene, and B (CTATA-
ATGTCCTGCACTGGG) within intron 3. The Gclc(e) allele was detected
using primers C (TAGTGAACGGTGTTAAAGG) within intron 3, and D
(TCACTGGATTCT CTCACC) within intron 6. The Gclc(wt) allele was
detected using primers B and C. Primers (GCGGTCTGGCAGTAAAAA-
CTATC, forward) and (GTGAAACAGC ATTGCTGTCACTT, reverse)
were used to detect the Cre transgene.
2.3. Isolation of mouse lung endothelial cells (MLEC) and primary lung
ﬁbroblasts
Mice were sacriﬁced by cervical dislocation and lungs were excised
and digested with collagenase from Clostridium histolyticum (Sigma,
St. Louis, MO). The mixed population obtained was subjected to posi-
tive selection with anti-ICAM-2 (BD Biosciences, San Jose, CA, USA)
and anti-IgG-coated magnetic beads (Invitrogen, Carlsbad, CA, USA);
the leftover mixed cell population (ﬁbroblast and macrophages) was
subjected to negative selection with anti-FCsRII/III (BD Biosciences,
San Jose, CA, USA). MLEC were cultured in EGM2 media and grown on
a mixture of ﬁbronectin (Sigma, St. Louis, MO), type I collagen (Thermo
Scientiﬁc, Rockford, IL, USA), and 0.1% gelatin (Sigma, St. Louis, MO)-
coated plates. Primary lung ﬁbroblasts were cultured in Dulbecco's
Modiﬁed Eagle's medium (DMEM) with 10% Fetal bovine serum sup-
plementation.
2.4. Western blot and densitometry analysis
After treatment, cells were washed with phosphate-buﬀered saline
(PBS) and lysed in 150 µl RIPA lysis buﬀer containing 150 mM NaCl,
0.1% sodium dodecyl sulphate (SDS), 1% sodium deoxycholate, 1% NP-
40 and 25 mM Tris–HCl pH 7.6, in the presence of protease (Complete,
Roche Diagnostics, Mannheim, Germany) and phosphatase inhibitors
(Sigma-Aldrich, St. Louis, MO). Cells were harvested by scraping,
samples were clariﬁed by centrifugation at 13,000 rpm for 15 min at
4 °C and protein concentration was measured with the BCA assay
(Thermo Scientiﬁc, Rockford, IL, USA). Equal amounts of protein
(40–80 μg) from the total extract were separated by electrophoresis
using an acrylamide/bisacrylamide (10%) gel and transferred to a ni-
trocellulose membrane (GE Healthcare, Germany) at 12 V for 20 min in
a semi-dry Trans-Blot Turbo system (Bio-Rad, Hercules, CA). After
blocking the membranes in 5% skimmed milk in TBS-T (10 mM), they
were incubated with the appropriate primary antibodies, anti-GCLc
(generous gift of Dr. Kavanagh's laboratory), anti-GCLm (1:1000; sc-
32251, Santa Cruz Biotechnology, CA, USA), anti-αSMA (1:1000; sc-
32251, Santa Cruz Biotechnology, CA, USA), anti-β-actin antibody
(1:15000; A1978, Sigma, St. Louis, MO), anti-tubulin (1:15000; T9026,
Sigma, St. Louis, MO), anti-eNOS (1:1000; 610297, BD Biosciences, San
Jose, CA, USA) and anti-p-eNOS (Ser1177) (1:1000; 9571, Cell
Signaling Technology, Boston, USA). Secondary antibodies against
rabbit and mouse were from LI-COR Biosciences (Lincoln, NE).
Densitometry of at least 3 Western blots for each experiment was done
using β-actin or glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
(1:15000; Sigma, St. Louis, MO) as housekeeping controls for the total
levels of protein loaded. Phospho eNOS signals were corrected by the
levels of total eNOS, after normalization with β-actin. These analyses
were represented in bar graphs showing the mean± SEM of protein
respective to control conditions.
2.5. Real-time PCR
Total RNA was isolated with miRNeasy Mini Kit (Qiagen, California,
USA). Reverse transcription was performed with 1 µg/µl mRNA sample
using iScriptTM cDNA Synthesis Kit (Bio-Rad, Hercules, CA). qRT-PCR
was carried out with the iQ™SYBR Green Supermix (Bio-Rad, Hercules,
CA), using speciﬁc primers for mRNA ampliﬁcation (Sigma, St. Louis,
MO). The relative quantiﬁcation of gene expression was determined
using the 2-ΔΔCt method [26]. Using this method, we obtained the fold
changes in gene expression normalized to an internal control gene, G-
APDH. The sequences of the primers were: mouse GAPDH, forward: 5′-
GAGTCAACGGATTTGGTCGT-3′, reverse: 5′-TTGATTTTGGAGG GATC-
TC G-3′; mouse FN, forward: 5′-AGAGGCTGTGTTGCTGTGAA-3′, re-
verse: 5′-AA ATCCATCGGGTATCTGGA-3′; mouse Col1α1, forward: 5′-
TGG AGAGGAAAGTGGCGGGGAG-3′, reverse: 5′-GCCTCACGGAACCA-
CGAACG-3′; mouse GCLm, forward: 5′-CGGACGACCTGGTGAGAGA-3′,
reverse: 5′-CATTGTGTCCCCTAATGCCTT-3′; mouse NRF2, forward: 5′-
GTGTTGGG AATGGTCGTGGGGAATG-3′, reverse: 5′-CCAATGCCACG-
GCCATAGCAGTA GC-3′; mouse α-SMA, forward: 5′-CTGACAGAGGC-
ACCACTGAA-3′, reverse: 5′-CATCTCCA GAGTCCAGCACA-3′.
2.6. GSH assay
Reduced and oxidized forms of GSH were measured in MLEC uti-
lizing the luminescence GSH-Glo and 2GSH/GSSG assays, based on the
conversion of a luciferin derivative into luciferin in the presence of GSH
(Promega, Wisconsin, USA) according to the manufacturer's instruc-
tions. The cells were analyzed on a luminescence plate reader (Glomax,
Promega, Wisconsin, USA).
2.7. ROS production
MLEC were plated in a 96-well plate to reach a conﬂuence of 70%.
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The cells were treated with or without 10 μM of Cyclosporine A (Sigma,
St. Louis, MO) for 2 h, 25 μM 2,3-Dimethoxy-1,4-naphthoquinone
(DMNQ) (Sigma, St. Louis, MO) for 1 h or 200 μM H2O2 (Sigma, St.
Louis, MO) for 10 min at 37 °C. The cells were then stained with 5 μM of
CellROX® Deep Red Reagent (ThermoFisher Scientiﬁc, Waltham, MA)
by adding the probe to the complete medium and incubating the cells at
37 °C for 30 min. The cells were then washed with PBS and analyzed on
a ﬂuorescence plate reader using the following wavelengths: emission
665 nM, excitation 644 nM (Glomax, Promega, Wisconsin, USA).
2.8. Immunoprecipitation assay
MLEC from Gclc(e/+) and Gclc(f/f) were seeded into 100 mm
culture dishes to reach a conﬂuence of 70% and deprived of FBS for
16 h before treatments. They were treated with or without GSNO 50 μM
for 1 h. Cells were lysed in RIPA lysis buﬀer, harvested by scraping and
samples were cleared by centrifugation at 13,000 rpm for 15 min at
4 °C. Protein A/G-coupled agarose beads (Thermo Scientiﬁc, Rockford,
IL, USA) were pre-incubated with anti-eNOS antibody (1:10; 610297,
BD Biosciences, San Jose, CA, USA) for 1 h at 4 °C and then incubated
for 2 h with cell lysate at 4 °C. IgG1κ antibody (1:10, 401401,
Biolegend, San Diego, CA, USA) was used in the negative control con-
dition. After incubation, eNOS immunoprecipitation product was wa-
shed three times with cold PBS buﬀer. 1 × SDS loading buﬀer was used
to elute eNOS for immunoblotting analysis of eNOS S-glutathionylation,
using primary antibodies against eNOS (1:1000; 610297, BD
Biosciences, San Jose, CA, USA) and GSH (1:1000; 101-A, Virogen,
Watertown, NY, USA).
2.9. Vascular reactivity
The animals were brieﬂy exposed to a chamber ﬁlled with carbon
dioxide until they fell unconscious and then immediately sacriﬁced by
cervical dislocation. The mesentery was removed, and placed in a Petri
dish containing Krebs-Henseleit solution (KHS) (KHS; composition:
NaCl 115, CaCl2 25, KCl 4.6, KH2PO4 1.2, MgSO4.7H2O 1.2, NaHCO3
25, glucose 11.1 and Na2 EDTA 0.03.) at 4 °C. The third branch me-
senteric arteries were dissected from GCLc(f/f) and GCLc(e/+) mice
(mean internal diameter ranged between 200 and 400 µm). The arteries
were cleaned free of fat and connective tissue under a light microscope
and mounted as ring preparations on a small vessel myograph [27] to
measure isometric tension. Arteries were bathed in KHS at 37 °C con-
tinuously bubbled with a 95% O2-5% CO2 mixture, which yields a pH of
7.4 and their passive tension and internal circumference were de-
termined. The arteries were subjected to optimal tension (90% of the
tension equivalent to an intramural pressure of 100 mm Hg. After
30 min of stabilization, the vessels were exposed to 125 mmol/L KCL
for 2 min in order to check their functional integrity. Segments failing
to achieve a maximum active tension equivalent to a pressure of
100 mmHg were rejected for experimental purposes.
The arteries were contracted with the concentration of 1 μmol/L
noradrenaline (NA), required to produce approximately 80% of the
maximum response. Contractility to NA was not statistically diﬀerent
among groups. Relaxation response to acetylcholine (ACh) was subse-
quently assessed by adding cumulative concentrations of the vasodi-
lator at 2 min intervals (ﬁnal bath concentrations 10 nmol/L to
10 μmol/L for ACh). Some microvessels from male mice were pre-in-
cubated with increasing concentrations of tetrahydrobiopterin (BH4)
(10 µM) 120 min before and during the administration of NA and ACh.
Other vascular segments were treated with 10 µM N-acetylcysteine
(NAC) and 10 µM GSH-ethyl-ester for 30 min in advance and during the
administration of NA, and ACh, respectively. Finally, in selected ex-
periments, instead of ACh, concentration-dependent curves to the en-
dothelium-independent vasodilator sodium nitroprusside (SNP;
1 nmol/L to 10 μmol/L) were performed.
2.10. Unilateral ureteral obstruction (UUO)
Studies were conducted according to the NIH Guide for the Care and
Use of Laboratory Animals. Male Gclc(f/f) and Gclc(e/+) mice (12–14-
week-old) were anesthetized, the left ureter was ligated, and the kidney
was obstructed (n = 6 per group), using the contralateral kidney as
control (non-obstructed), as previously described [28]. Animals were
sacriﬁced at 10 days after surgery. Kidneys were perfused in situ with
cold saline before removal. Half a kidney was snap frozen in liquid
nitrogen for RNA and protein studies.
2.11. Renal histology
At the end of the UUO procedure, both kidneys were perfused with
PBS and ﬁxed in 4% neutral buﬀered formalin for 24 h. Sections of 3-
μm thickness were stained with Sirius red as described previously [29].
Fibrosis analysis was deﬁned as the percentage of Sirius Red area in the
entire kidney section excluding perivascular staining and the evaluation
was performed by a renal pathologist in a blind-folded fashion. Mi-
crophotographs were obtained using a digital camera (Nikon D3) con-
nected to a Nikon's Eclipse TE2000-U light microscope (Nikon Instru-
ments Europe B.V., Badhoevedorp, The Netherlands).
2.12. Statistical analysis
Statistical analysis was performed with GraphPadPrism (GraphPad
Software). Data are expressed as means± SEM. Diﬀerences among
groups with one experimental condition were assessed with
Kruskal–Wallis test with Dunn's correction. Two-way ANOVA with
Bonferroni correction was used to analyze diﬀerences among groups
exposed to more than one condition. Diﬀerences between only two
groups were analyzed with Mann–Whitney two-tailed test.
3. Results
3.1. Generation of endothelial-speciﬁc Gclc(e/+) knock-out mice and
genotypic characterization
To evaluate the contribution of endothelial GSH to vascular function
we intercrossed Tie2-Cre (+/+) mice, that express Cre recombinase
speciﬁcally in the endothelium under the control of the Tie2 promoter
[30], with Gclc(f/f) mice. In the latter, exons 4 and 6 of the Gclc allele
are ﬂanked by LoxP sites [25]. The possible genotypes to be obtained
are depicted in Fig. 1. After several rounds of crossing we were able to
generate endothelial haplo-insuﬃcient Gclc mice, here termed Gclc(e/
Fig. 1. Breeding scheme for generating speciﬁc Gclc endothelial null mice. Tie2-Cre
(+/+) male mice were crossed with female Gclc ﬂoxed [Gclc (f/f)] mice to generate F1
generation. Male mice from F1 generation were crossed with female Gclc(f/f) with the
aim to obtain homozygous mice with endothelial-speciﬁc deletion of Gclc [Gclc (e/e)].
The expected Mendelian frequency of all 4 genotypes is indicated, though Gclc (e/e) mice
were not obtained. Gclc(e/+) endothelial haplo-insuﬃcient mice were obtained and
utilized in this study and Gclc(f/f) were used as controls.
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+). In Tie2-Cre-positive Gclc(f/f) mice, we detected endothelial-speciﬁc
recombination of the Gclc(f) allele, Gclc(e) allele by PCR using the
primers indicated in Fig. 2A and described in the methods section. As
expected, we did not detect the Gclc(e) allele in DNA isolated from tails
of Gclc(f/f) mice lacking Tie2-Cre (Fig. 2B, lane 1). However, we de-
tected Gclc(wt) allele in both, positive and negative Tie2-Cre mice
(Fig. 2B, lanes 2 and 3). As shown in Fig. 2B, lane 4 we detected the
presence of Gclc (wt) as well as Gclc (e/+), supporting that all Tie2-Cre
positive mice are heterozygous. In spite of further attempts to generate
homozygous mice lacking endothelial GCLc we were unable to breed
these, due perhaps to embryonic or perinatal lethality associated to this
phenotype [31].
3.2. Eﬀects of endothelial GCLc decrease on the redox state
In order to characterize GCLc expression in endothelial cells, we
isolated mouse lung endothelial cells and ﬁbroblasts from Gclc(f/f) mice
and Gclc(e/+) as indicated in Methods. GCLc protein expression was
signiﬁcantly downregulated in the endothelium from haplo-insuﬃcient
mice respect to the control mice. However, we did not observe sig-
niﬁcant changes in the modiﬁer subunit GCLm (Fig. 3A), suggesting
that there are no evident compensatory responses to the deﬁcit of the
catalytic subunit. The protein levels of GCLc and GCLm in lung
ﬁbroblasts were similar in the control and the haplo-insuﬃcient mice,
thus attesting to the speciﬁcity of the endothelial deletion (Fig. 3B).
To evaluate the functional relevance of GCLc reduction, we mea-
sured GSH levels in these cells. Gclc haplo-insuﬃciency was associated
with a decrease in GSH levels by 80% respect to control mice (Fig. 4A).
We did not detect signiﬁcant changes in the abundance of the oxidized
form of GSH, GSSG (data not shown). Exposure of MLEC from Gclc(e/
+) to previously described electrophiles [32] as well as to H2O2,
showed enhanced ROS generation compared to identically treated
control MLEC (Fig. 4B). GSH depletion and increased oxidative stress
trigger endothelial dysfunction and eNOS uncoupling [33]. The analysis
of eNOS activation is a good indicator of vascular function; therefore we
studied redox-dependent phosphorylation of Ser 1177 [34]. Whereas
eNOS phosphorylation levels increased along time of exposure to H2O2
in Gclc(f/f) endothelial cells, MLEC from haplo-insuﬃcient mice did not
show any signiﬁcant time-dependent increase in eNOS phosphorylation
(Fig. 4C). Of importance, MLEC from Gclc (e/+) exhibited enhanced
eNOS S-glutathionylation in basal conditions (Fig. 4D), thus providing a
biochemical basis for eNOS uncoupling [35]. Overall, these data sup-
port that endothelial depletion of GCLc levels results in signiﬁcant
perturbation of redox homeostasis, manifested in a reduced capacity to
handle electrophilic stress and eNOS dysfunction.
3.3. Haplo-insuﬃciency of the Gclc gene is associated with endothelial
dysfunction in male mice
To evaluate the consequences of Gclc haploinsuﬃciency on en-
dothelial function we isolated mesenteric arteries from Gclc(f/f) and
Gclc(e/+) mice and studied their reactivity as indicated in Methods.
We ﬁrst studied endothelial-dependent relaxation in vessels from Gclc
(f/f) and Gclc(e/+) male and female mice. Gclc(e/+) male mice ex-
posed to concentration-dependent relaxations evoked by acetylcholine
(ACh) showed an impairment in the contractile response compared to
control mice, whereas in female mice no signiﬁcant diﬀerences were
detected (Fig. 5A). No diﬀerences among groups in vascular relaxation
elicited by sodium nitroprusside (SNP) were observed (Fig. 5B). Due to
the obvious gender diﬀerences in vascular relaxation only male mice
were chosen to perform the rest of the vascular reactivity studies.
3.4. Endothelial dysfunction related to Gclc haplo-insuﬃciency is
attenuated by tetrahydrobiopterin (BH4) and GSH ethyl-ester
To understand the mechanisms involved in endothelial dysfunction
in Gclc(e/+) mice, we pre-incubated mesenteric vessels from Gclc(f/f)
and Gclc(e/+) mice with agents potentially modulating GSH levels or
eNOS function, namely NAC, the permeable analog of GSH, GSH ethyl-
ester (GSH-EE) and the eNOS cofactor tetrahydrobiopterin (BH4). Pre-
treatment with BH4 also resulted in increased amelioration of the vas-
cular dysfunction associated to Gclc haplo-insuﬃciency (Fig. 6A). Pre-
treatment of vessels with NAC was not accompanied by a signiﬁcant
improvement in vascular reactivity in Gclc (e/+) mice (Fig. 6B),
whereas pre-treatment with GSH-EE was associated with increased re-
laxation in response to the higher concentrations of ACh (Fig. 6C).
Taking together these results indicate that endothelial dysfunction of
Gclc(e/+) mice is associated with reduced GSH bioavailability that can
be compensated by improving eNOS function through the addition of
critical cofactors that limit or revert its uncoupled state.
3.5. Haplo-insuﬃciency of endothelial Gclc results in a moderate renal
ﬁbrotic phenotype
As described in previously published work GCLc and GCLm are
signiﬁcantly downregulated after induction of renal ﬁbrosis using the
unilateral ureteral obstruction (UUO) model [23]. To evaluate if the
reduction of GCLc basal levels present in the Gclc(e/+) mice could have
an eﬀect in renal ﬁbrogenesis, we performed the UUO procedure in
Fig. 2. Genetic validation of GCLc(e/+) endothelial haplo-insuﬃciency. A)
Schematic of the wild-type Gclc allele (+), targeting-construct targeted allele (f), and the
deleted allele (e), following Cre-mediated recombination. NEO, neomycin-resistance
mini-cassette, and HSV-TK, herpex simplex virus thymidine kinase mini-cassette, re-
present genes used as selectable markers. The positions of primers for PCR analysis are
shown as arrows. B) PCR analysis of genomic DNA for the Tie2-Cre and Gclc alleles. The
203-pb BC, 200-pb AB and 180-pb CD bands represent the Gclc (+), Gclc (f) and Gclc (e)
alleles, respectively.
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these mice and determined the abundance of several ﬁbrosis markers.
Even though the expression of GCLc was evaluated in whole kidney
tissue and not exclusively in the vascular compartment, the levels of
GCLc were reduced after the UUO procedure and this reduction was
enhanced in Gclc(e/+) (Fig. 7A). The abundance of canonical ﬁbrotic
markers such as Col1a1 and ﬁbronectin were also increased in Gclc
haplo-insuﬃcient kidneys (Fig. 7B–C). In contrast, although UUO pro-
moted a dramatic increase in the mRNA or protein levels of α-SMA, no
signiﬁcant diﬀerences between control and haplo-insuﬃcient mice
were detected (Fig. 7D–E).
We checked for the presence of a homeostatic redox response after
the challenge of UUO. Of interest, there was no diﬀerential compen-
sation of GCLm levels in Gclc(e/+) mice but in contrast, the UUO-de-
pendent increase in the levels of Nrf2, the master regulator of anti-
oxidant responses, was completely absent in the Gclc haplo-insuﬃcient
mice (Fig. 7F–G).
To evaluate the presence of kidney ﬁbrosis, histological analysis
with Sirius Red was performed in renal tissue from 3 WT and 3 Gclc(e/
+) mice subjected to the UUO procedure. As shown in Fig. 8A the fold-
change in the intensity of the Sirius Red stained areas was generally
higher in the obstructed kidneys from the Gclc(e/+) animals. A re-
presentative micrograph of Sirius Red-stained renal tissue from one WT
and one Gclc(e/+) is shown in Fig. 8B.
4. Discussion
In the present study we have studied the speciﬁc contribution of
endothelial GSH to endothelial function. Using murine lung endothelial
cells (MLEC) from endothelial-speciﬁc Gclc haplo-insuﬃcient Gclc(e/
+) mice we have shown a reduction in GSH levels as well as increased
ROS levels, reduced phosphorylation of eNOS (Ser 1177) and increased
eNOS S-glutathionylation. Further, we demonstrated that GSH deﬁ-
ciency impairs endothelium-dependent vasodilation in Gclc(e/+) male
mice, which was corrected by pre-incubation with ethyl-ester GSH and
BH4. In addition, we have also studied the contribution of endothelial
GSH synthesis to renal ﬁbrosis. Using the UUO model in WT and Gclc(e/
+) mice we have shown that obstructed kidneys from Gclce/+) mice
exhibited increased deposition of ﬁbrotic markers and reduced Nrf2
levels. This report demonstrates that endothelial GSH constitutes a
major protective mechanism in endothelial dysfunction and UUO-in-
duced renal ﬁbrosis.
GCLc is the rate-limiting enzyme for GSH biosynthesis. To evaluate
the contribution of GCLc to endothelial function we generated en-
dothelial-speciﬁc haplo-insuﬃcient Gclc(e/+) mice. We also attempted
to generate homozygous mice lacking endothelial Gclc but we were
unable to breed them. It is conceivable that the complete genetic de-
ﬁciency of Gclc leads to a lethal embryonic or perinatal phenotype as it
has been previously described that complete deﬁcient homozygosity of
Gclc results in death before gestational day 13, whereas the Gclc(+/-)
heterozygotes are viable and fertile [31]. Hence, our data also support
that GSH synthesis is essential for early mouse development. GSH is
particularly critical for normal embryonic development of the visceral
yolk sac or the ectoplacental cone, highly vascularized tissues [31]. Of
interest, other tissue speciﬁc Gclc-null homozygous mice have been
characterized, including those targeting the epidermis and liver
[25,36]. Keratinocyte-speciﬁc deﬁciency in Gclc caused DNA and mi-
tochondrial damage, as well as a strong reduction in keratinocyte via-
bility, partially aﬀecting the epidermal architecture and healing [36].
Similarly, the selective loss of GSH synthesis in hepatocytes leads to
steatosis that may be accompanied by mitochondrial damage and
Fig. 3. GCLc characterization in MLEC and lung ﬁbroblasts isolated from Gclc(f/f) and Gclc(e/+)mice. A) Western blot analysis (left) and quantiﬁcation (right) of GCLc and GCLm
in MLEC isolated from Gclc(f/f) (3 specimens) and Gclc(e/+) (4 specimens) mice. B) Western blot analysis (left) and quantiﬁcation (right) represents GCL protein expression in mice lung
ﬁbroblasts isolated from Gclc(f/f) (2 specimens) and Gclc(e/+) (3 specimens) mice. Bar graphs show densitometric analysis for GCLc and GCLm relative to housekeeping, β-actin. Data
represent mean± SEM, **p<0.01 compared to GCLc from Gclc(f/f) mice MLEC.
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hepatic failure [25].
Our results show that GCLc protein expression was signiﬁcantly
downregulated in approximately 40% in MLEC derived from haplo-in-
suﬃcient mice. Of note, this was reﬂected by 80% decrease in en-
dothelial GSH levels. Overall, these reductions are higher than those
observed in the liver of whole haplo-insuﬃcient mice (20%) [31],
pointing to an enhanced repercussion of the genetic modiﬁcation
within the vascular endothelium. Genetic targeting of the Gclc subunit
was not accompanied by compensatory changes in the GCLm subunit.
MLEC from Gclc(e/+) showed increased basal and stimulated ROS le-
vels in response to several electrophilic stimuli, suggesting a weakened
endogenous antioxidant response, even in the absence of diﬀerences in
the level of oxidized GSH. In humans, mutations in the GCLc gene may
lead to reduction levels of GSH as low as 2% of normal in their ery-
throcytes and aﬀected individuals suﬀer hemolytic anemia [37]. Fur-
thermore, the− 129T polymorphism within the promoter region of the
GCLc gene suppresses GCLC gene induction response to oxidant agents
and it correlates with coronary endothelial vasomotor dysfunction [38].
Endothelial nitric oxide synthase (eNOS) is a critical regulator of
vascular homeostasis by generating nitric oxide (NO) from L-arginine
oxidation. eNOS activity is tightly regulated by posttranslational mod-
iﬁcations [39]. Phosphorylation at diﬀerent sites may have gain or loss
functional consequences [40,41]. In general, it is accepted that Ser-
1177 phosphorylation, which may be elicited by the PI3K-Akt signaling
pathways, conveys eNOS activation [42]. In opposition, a reduction in
the levels of phosphorylation at this Ser-1177 site in response to ap-
propriate stimuli can be interpreted as eNOS inactivation [41]. Of in-
terest, the redox state in the cell is able to regulate eNOS Ser-1177
phosphorylation levels [42]. It has been shown that in endothelial cells
under an unbalanced electrophilic tone, eNOS may become uncoupled
and transform into a new potential source for the generation of su-
peroxide radical anion (O2-). eNOS uncoupling is linked to an increased
Fig. 4. GSH and oxidative stress characterization in GCLc(e/+) mice. A) GSH levels in MLEC from Gclc(f/f) and Gclc(e/+) mice. B) ROS levels in MLEC from GCLc(f/f) and GCLc(e/
+)mice in basal conditions and after Cyclosporin A, DMNQ and H2O2 treatment. C) Western blot analysis (left) and quantiﬁcation (right) of p-eNOS (Ser1177) in MLEC isolated from Gclc
(f/f) and Gclc(e/+) mice. Bar graphs show densitometric analysis relative to housekeeping, eNOS and β-actin. D) Western blot analysis (left) and quantiﬁcation (right) of eNOS S-
glutathionylation after eNOS immunoprecipitation in MLEC isolated from Gclc(f/f) and Gclc(e/+) mice. Anti-eNOS and IgG1κ antibodies were used as positive and negative im-
munoprecipitation controls, respectively in MLEC protein samples. Bar graphs show densitometric analysis relative to eNOS, Data are mean± SEM of three independent experiments,
**p< 0.01 and ***p< 0.001 compared to control Gclc(f/f) mice MLEC. #p<0.05 and ##p<0.01 compared to Gclc(f/f) mice MLEC within the corresponding treatment or time-point.
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presence of the monomeric form of the enzyme. It is also currently
accepted that a critical perturbation leading to its uncoupled state is the
relative deﬁciency of the eNOS catalytic cofactor tetrahydrobiopterin
(BH4) [10]. Furthermore, eNOS can suﬀer S-glutathionylation at some
speciﬁc cysteine residues. This mixed disulﬁde(s) formation has been
also proposed as a mechanism for eNOS uncoupling [10]. We have
observed that MLEC from endothelial Gclc haplo-insuﬃcient mice
showed reduced phosphorylation of eNOS (Ser 1177) and increased
eNOS S-glutathionylation, compared to MLEC from wild type (WT)
mice. The increased electrophilic tone present in the MLEC from Gclc(e/
+) mice could contribute to both BH4 depletion and consequently in-
creased eNOS S-glutathionylation, resulting in an uncoupled state [43].
However, the precise mechanism(s) and order by which these bio-
chemical modiﬁcations are occurring in the Gclc haplo-insuﬃcient cells
have not been explored in this study and will require further in-
vestigation.
The endothelium controls the vascular tone by releasing vasoactive
substances in response to physical and chemical signals. eNOS-derived
NO has emerged as the most notable endothelium-derived vasodilator.
However, perturbations in the vascular tone are germane to vascular
pathologies, such as hypertension, vasculitides, atherosclerosis and
diabetic vasculopathy [44]. Our studies in mesenteric arteries demon-
strated impaired endothelium-dependent vasodilation in Gclc(e/+)
male mice in response to ACh, which was corrected by pre-incubation
with BH4 and GSH ethyl-ester. However, no diﬀerences were observed
in relaxant responses elicited by SNP among Gclc(e/+) and WT mice-
derived mesenteric vessels, supporting the speciﬁcity of the endothelial
genetic targeting. Improvement of endothelial vasodilation by pre-in-
cubation with GSH ethyl-ester and BH4 can be attributed to a po-
tentiation of the NO/cGMP pathway-mediated relaxation of smooth
muscle since BH4 preserves eNOS dimerization and improves
endothelial function through ﬂavin-mediated electron transference
[45]. BH4 availability in the mesenteric vascular bed of Gclc(e/+) male
mice can also be hampered by a decreased biosynthetic rate or in-
creased oxidation as previously described [44]. It has been reported
that modulation of the Ser1177 phosphorylation site aﬀects en-
dothelium-dependent vasodilation [41]. Furthermore, restoring GSH
levels by pre-treatment with GSH-ethyl-ester would reduce oxidative
environment in Gclc-deﬁcient mesenteric endothelial and could also
enhance the activity of glutathione-dependent enzymes such as glu-
taredoxins, which have been shown to revert eNOS S-glutathionylation
with restoration of NO synthase activity [46]. In our hands the anti-
oxidant molecule NAC, which is expected to increase the nucleophilic
tone and can serve as a precursor for GSH, did not signiﬁcantly revert
the impaired endothelium-dependent vasodilation in GCLc (e/+) male
mice, although we observed a tendency to improve impaired relaxation.
It is possible that limited permeability of the molecule resulted in only
modest enhanced endothelial bioavailability of GSH that was not en-
ough to display a full reversion in the deranged vascular reactivity of
Gclc haplo-insuﬃcient mice. Nevertheless, our results support that en-
dothelial dysfunction of Gclc(e/+) mice is associated with reduced GSH
bioavailability that can be compensated by improving eNOS function
through the addition of critical cofactors.
One striking ﬁnding in this study is the observation that there was a
gender-related eﬀect in the vascular relaxation response, as Gclc haplo-
insuﬃcient female mice did not show any diﬀerence compared to WT
mice. The importance of estrogens on endothelial function has been
established since reports of the last century [47]. At the biochemical
level early studies showed that estradiol induces eNOS translocation to
the cytosol and activation [48]. In addition, estrogens regulate anti-
oxidant enzyme expression and function [48]. Hence, one plausible
explanation is that inherent hormonal gender diﬀerences could
Fig. 5. Endothelial function. Vascular relaxation studies in mesenteric arteries of haplo-insuﬃcient mice. (A) Eﬀect of Gclc speciﬁc deletion on the endothelium-dependent
relaxations induced by acetylcholine (ACh, 10 nmol/L to 10 μmol/L) in isolated mesenteric arteries from Gclc(f/f) and Gclc(e/+) mice. (B) Eﬀect of Gclc speciﬁc deletion on the
endothelium-independent relaxations induced by sodium nitroprusside (SNP, 10 nmol/L to 100 μmol/L) in isolated mesenteric arteries from Gclc(f/f) and Gclc(e/+) mice. Data are
expressed (means ± SEM) as the percentage of the previous contraction induced with 1 μmol/L noradrenaline (NA) in segments obtained from 6 to 14 animals. ***p< 0.001 compared
to mesenteric arteries from Gclc(f/f) mice.
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compensate for the reduction of GSH levels in the vascular endothelium
of female mice through NO-dependent mechanisms. More recent stu-
dies have also pointed to the capacity of estrogens to increase avail-
ability of BH4 [49] and also to the capacity of NO and SOD-1 to account
for reduced neointimal hyperplasia in female mice [50]. The molecular
mechanisms behind the observed diﬀerences in our study were not
explored. Although, we believe it is sound to hypothesize that they
might be related to the profound inﬂuence of an estrogenic environ-
ment on vascular function through the aforementioned eﬀects.
Whereas in our model we did not observe compensation for the
genetic deﬁciency of Gclc by increased expression of the other com-
ponent of the enzyme, Gclm, rigorous studies of vascular function per-
formed in the whole null model of Gclm(–/–) shed important light on
the consequences of GSH deﬁciency for endothelial function [18].
These mice had an 80% and 25% reduction in aortic GSH levels in the
homozygous and heterozygous null mice, respectively. This was
accompanied by increased levels of GSSG and altered endothelial-de-
pendent vascular relaxation. Strikingly, relaxation for higher con-
centrations of acetylcholine was improved in homozygous Gclm null
mice compared to control or heterozygous animals. Our study under-
scores that the approach of selectively targeting the endothelium in-
corporates added value to understand the role of endothelial GSH
homeostasis and prevents any confounding factor inherent to total tis-
sular suppression of a key GSH biosynthetic pathway.
Kidney ﬁbrosis is the ﬁnal outcome of many prevalent renal dis-
eases, such as hypertensive nephropathy, diabetes mellitus and aging.
The establishment of ﬁbrosis leads eventually to chronic kidney disease
or end-stage renal disease [51]. Transforming growth factor beta (TGF-
β) is the one of the most potent and ubiquitous ﬁbrogenic cytokines and
its increased expression is present in almost all types of organ ﬁbrosis
and in diﬀerent models of experimental ﬁbrosis including UUO. It is
accepted that there is a bidirectional relationship between the redox
Fig. 6. Mechanisms involved in the endothelium impairment by Gclc deﬁciency. Eﬀects of (A) tetrahydrobiopterin, BH4 (10 µM), (B) N-acetylcysteine, NAC (10 µM), (C) glutathione
ethyl-ester, GSH (10 µM) on the impairment produced by Gclc deﬁciency on endothelium-dependent relaxations induced by ACh (10 nmol/L to 10 μmol/L) in isolated mesenteric arteries
from Gclc(f/f) and Gclc(e/+) mice. Data are expressed (means ± SEM) as the percentage of the previous contraction induced with 1 μmol/L NA in segments obtained from 6 to 14
animals. The same set of control mesenteric arterial segments were used in panels A and B, whereas a diﬀerent set was employed to generate data shown in panel C. Contractility to NA
was not statistically diﬀerent among groups. *p<0.05, **p< 0.01 and ***p<0.001 compared to mesenteric arteries from Gclc(f/f) mice.
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state and TGF-β activation [24]. The homeostatic role provided by the
redox pair GSH/GSSG is essential for the redox-related pathophysiolo-
gical mechanisms underlying ﬁbrosis. The concentration of GSH
decreases in experimental ﬁbrosis models, in human ﬁbrotic diseases
and several cell types including endothelial cells, hepatocytes, epithe-
lial cells, and ﬁbroblasts, whereas GSH replenishment suppresses TGF-
Fig. 7. Eﬀect of the haploinsuﬃciency of Gclc on renal ﬁbrosis. (A) Western blot analysis (left) and quantiﬁcation (right) of GCLc in kidney samples from Gclc(f/f) and Gclc(e/+)
mice after 10 days of unilateral ureteral obstruction (UUO). (B-D) qRT-PCR analysis for mRNA expression of Col1α1 (B), FN (C) and α-SMA (D) in kidney samples from Gclc(f/f) and Gclc
(e/+) mice after 10 days of UUO. (E) Western blot analysis (left) and quantiﬁcation (right) against α-SMA in kidney samples from Gclc(f/f) and Gclc(e/+) mice after 10 days of UUO. (F-
G) qRT-PCR analysis for mRNA expression of Gclm (F) and Nrf2 (G) in kidney samples from Gclc(f/f) and Gclc(e/+) mice after 10 days of UUO. All bar graphs represent mean± SEM (n
= 6 mice in each group), **p< 0.01 and ***p< 0.001 compared to control kidney from Gclc(f/f) mice. ##p<0.01 and ###p<0.001 compared to its corresponding Gclc(f/f)
condition.
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β’s ﬁbrogenic activity [14]. Endothelial dysfunction is a multifaceted
condition that plays a central role in complications related to kidney
diseases through the regulation of oxygen levels, the inﬂammatory re-
sponse, cellular crosstalk and the generation of renal mesenchymal
cells. To study the contribution of endothelial GSH synthesis to renal
ﬁbrosis we employed the UUO model in WT and Gclc(e/+) mice. We
observed that obstructed kidneys from these mice exhibited increased
deposition of ﬁbrotic markers and an enhanced pattern of interstitial
ﬁbrosis as demonstrated by Sirius Red staining (Fig. 8A), in comparison
to WT mice. Even though the ﬁbrotic phenotype was only moderately
potentiated by the endothelial haplo-insuﬃciency, it is important to
keep in mind that GSH synthesis was only targeted in endothelial cells,
while the potential source of myoﬁbroblasts (pericytes, resident ﬁbro-
blasts, epithelial cells) are predicted to maintain intact redox home-
ostasis. It is precisely this circumstance that confers signiﬁcance to our
observations, as the vascular endothelium represents only a minor
portion of the whole kidney tissue albeit the speciﬁc deﬁcit of GSH
appears to be important for the ﬁbrotic response. However, the fact that
we used the Tie2-Cre model to generate the GCLc null mice poses a
limitation to our study as, in addition to its expression in endothelial
cells, Tie2 has been also described in certain hematopoietic cell lines
[52,53]. The ﬁrst stages of ﬁbrogenesis are characterized by a marked
inﬂammatory response. In this regard, an unbalance in macrophage
type populations and an active role of monocytes in angiotensin II-
mediated vascular dysfunction and ﬁbrogenesis have been reported
[54,55]. The homeostasis of GSH is critical for immune cell f unction
and several reports have illustrated this fact, in particular in the context
of atherogenesis and T-cell activation [56–58] In our endothelial dys-
function model, due to the nature of the endothelial reactivity experi-
ments it is reasonable to assume a limited contribution of the immune
response to the endothelial relaxation impairment. Nevertheless, in the
case of renal injury associated to the UUO model, macrophage activa-
tion of the proinﬂammatory M1 population and recruitment of immune
(mainly T) cells play an active role. In these conditions, the in-
ﬂammatory cytokines in the ﬁbrotic milieu lead to an increased pro-
duction of proﬁbrotic mediators such as TGF-β [59]. As stated above, an
unbalance in the oxidative stress levels in macrophages can promote the
polarization towards an M1 proinﬂammatory and proﬁbrotic pheno-
type. Therefore GSH depletion in immune cells would also enhance
renal ﬁbrosis progression. Since inﬁltrating monocytes/macrophages
negatively aﬀect vascular function, we may expect an ulterior crosstalk
between the immune and endothelial population that could contribute
to perpetuate ﬁbrogenesis. All these are important avenues to be ex-
plored in future work.
The maintenance of adequate nucleophilic power provided by GSH
is essential to prevent ﬁbrogenesis and the molecular bases for this are
well established. Jardine et al. reported that TGF-β-mediates GCLc
regulation. TGF-β suppressed GCLc promoter activity through the in-
creased binding of c-Jun and Fra-1 dimers to the AP-1 cis-regulatory
site within the antioxidant response element (ARE) [22]. In keeping,
NAC and GSH showed a clear inhibitory eﬀect on the development of
ﬁbrosis in both patients and animal models [60]. In kidney injury, the
redox regulation of ﬁbrogenic pathways is related to several mechan-
isms including the state of oxidation of critical protein thiols [61]. Thus,
the disturbance of redox homeostasis in the kidney endothelial com-
partment is likely to contribute to ﬁbrogenesis as an intact endothelial
function is considered indispensable for mounting an appropriate tissue
repair response [62,63]. In the context of the antioxidant response the
Keap1-Nrf2 system has been proposed to be a therapeutic target for
renal protection [64]. Nrf2 is a key regulator of antioxidant defense
system that modulates the expression of several genes in response to
electrophilic stress including phase 2 response genes and antioxidant
enzymes such as GCL [23,65]. The activation of Nrf2 after the UUO has
been invoked as an attenuating mechanism for the development of
renal ﬁbrosis [66]. Our data conﬁrmed our previous reported ob-
servation whereby UUO-induced renal ﬁbrosis is associated with Gclc
downregulation [23], which was even more pronounced in kidneys
from haplo-insuﬃcient mice (Fig. 7A). Whereas UUO was able to
trigger an up-regulation of Nrf2 levels in WT mice, ﬁbrotic kidneys from
Gclc(e/+) mice failed to do so (Fig. 7G). A clear explanation for this
observation is not obvious as a reduction of GSH levels should be ex-
pected to induce a compensatory up-regulation of the antioxidant re-
sponse by increasing Nrf2 levels. However, the interplay of TGF-β
regulation with GSH is a complex one [67]. Moreover, the fact that only
endothelial cells were targeted for GCLc, precludes a clear-cut inter-
pretation of these results.
In conclusion, our data establish that the speciﬁc endothelial re-
duction of GSH levels increased basal and stimulated ROS levels, re-
duced phosphorylation of eNOS (Ser1177) and increased eNOS S-glu-
tathionylation, subsequently impairing endothelium-dependent
vasodilation and promoting renal ﬁbrosis following UUO. Thus, we
propose that endothelial GSH plays a critical role in endothelial func-
tion and the anti-ﬁbrotic response in the kidney.
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